Company
Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| silevertinib in combination with temozolomide | Phase 2 | Glioblastoma (GBM) |
Latest
No recent events.
Follow Black Diamond Therapeutics, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.